The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Subscribe To Our Newsletter & Stay Updated
